David Ramsay
Vermögen: 13 Mio $ am 31.05.2026
Vermögen: 13 Mio $ am 31.05.2026
David A. Ramsay was the founder of Bonti, Inc., founded in 2015, where the title held was Chief Financial Officer & Senior Vice President in 2018.
Current jobs include Director at EXUMA Biotech Corp.
since 2017 and Independent Director at Savara, Inc. since 2017.
Former jobs include Treasurer, VP & Director-Corporate Finance at Bausch Health Americas, Inc. from 1998 to 2000; Independent Director at La Jolla Pharmaceutical Co. from 2019 to 2022; Independent Director at Mast Therapeutics, Inc. from 2011 to 2017; Director at Axxora LLC; Chief Financial Officer & Vice President at Halozyme Therapeutics, Inc. from 2013 to 2015; Auditor at Deloitte & Touche LLP; Vice President & Controller at Security Pacific Asian Bank; Chief Financial Officer & Vice President at Lathian Systems, Inc. from 2000 to 2003; and Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. in 2026.
Education includes an undergraduate degree from the University of California, Berkeley in 1986 and an MBAistration from The Wharton School of the University of Pennsylvania in 1994.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAVARA, INC. 1,22 % | 06.04.2026 | 2 493 642 ( 1,22 % ) | 13 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAVARA INC. | Direktor/Vorstandsmitglied | 27.04.2017 |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Direktor/Vorstandsmitglied | 01.01.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Finanzdirektor/CFO | 08.06.2026 |
| LA JOLLA PHARMACEUTICAL COMPANY | Direktor/Vorstandsmitglied | 22.08.2022 |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments | Gründer | 01.10.2018 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Direktor/Vorstandsmitglied | 01.04.2017 |
| HALOZYME THERAPEUTICS, INC. | Finanzdirektor/CFO | 15.06.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Security Pacific Asian Bank
Security Pacific Asian Bank Major BanksFinance Commercial banking | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lathian Systems, Inc.
Lathian Systems, Inc. Advertising/Marketing ServicesCommercial Services Provides technology-based sales and marketing solutions for the life science industry | Commercial Services |
Axxora LLC
Axxora LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets life sciences research products | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments | Health Technology |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Commercial Services |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen